
Join to view full profile
3577 W 13 Mile Rdsuite 103Royal Oak, MI 48073
Phone+1 248-288-4500
Fax+1 248-267-6852
Dr. Venuturumilli is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Padmaja Venuturumilli is an oncology specialist based in Royal Oak, MI, with subspecialties in breast, gastrointestinal, and thoracic cancer. She completed her residency in Internal Medicine/Pediatrics from 2003 to 2007 at Corewell Health East Beaumont and pursued a fellowship in Medical Oncology at Corewell Health William Beaumont University Hospital from 2007 to 2009. Dr. Venuturumilli earned her MB;BS in 1991 from Osmania Medical College NTR UHS. Her expertise includes colorectal, breast, lung, and hereditary breast/ovarian cancers. She has contributed to the field with publications on topics such as the effects of intrathecal trastuzumab and methotrexate and the impact of vaginal estrogens on serum estradiol levels. She has been involved in clinical trials like hormone therapy with or without Everolimus for breast cancer and high-dose Cholecalciferol for premenopausal women at high risk for breast cancer. Dr. Venuturumilli has received recognition through her CMS Meaningful Use Stage 1 Certification and is a fellow of the FACP.
Education & Training
Corewell Health William Beaumont University HospitalFellowship, Medical Oncology, 2007 - 2009
Corewell Health William Beaumont University HospitalResidency, Internal Medicine/Pediatrics, 2003 - 2007
Osmania Medical College NTR UHSClass of 1991, MB;BS
Certifications & Licensure
MI State Medical License 2005 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PegasusEMR, Software Solutions Group, Inc, 2012, 2014-2015
- fellow FACP
Clinical Trials
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Publications & Presentations
PubMed
- 12 citationsRapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastasesJennifer Martens, Padmaja Venuturumilli, Lindsey Corbets, Daniel J. Bestul
Acta Oncologica. 2013-01-01 - 90 citationsEffects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a ...S. M. Wills, Anita Ravipati, Padmaja Venuturumilli, Cynthia Kresge, Elizabeth Folkerd
Journal of Oncology Practice. 2012-02-07
Professional Memberships
- Member
- american society of hematologyMember
- american college of physiciansFellow
- MAPIMember
Other Languages
- Telugu, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: